Ensuring a balance of available glucose and skeletal muscle uptake can be challenging with exogenous insulin administration, which also inhibits hepatic glucose release, and there is a significant risk of hypoglycaemia, both during and after exercise, in people with type 1 diabetes. The gene discussed is INS; the disease is type 1 diabetes mellitus.